Scientific Program
| Day 1 Friday, 20th of September 2024 |
|
| Time | Session |
| 08:30 - 09:00 | Opening Ceremony Nicoleta Antone, Patriciu Achimaș-Cadariu, Alexandru Eniu |
| 09:00 - 10:30 | Session I - Breast Cancer Center Experience in Radiology Moderators: Carmen Lisencu, Roxana Pintican |
| 09:00 - 09:15 | Round 1 of Population Screening Organized in the North-West Region. Results and Challenges Carmen Lisencu |
| 09:15 - 09:30 | Comparative Evaluation of the Axilla in Breast Cancer Patients Roxana Pintican |
| 09:30 - 09:45 | Histological Confirmation of Metastatic Disease in Breast Cancer Through Minimally Invasive Procedures Andrei Roman |
| 09:45 - 09:50 | Discussions |
| 09:50 - 10:10 | The impact of Sacituzumab govitecan in mBC clinical practice Andrei Ungureanu |
| 10:10 - 10:30 | Future perspectives of Ribociclib: rationale and opportunities in eBC Andrei Ungureanu |
| 10:30 - 11:00 | Coffee Break |
| 11:00 - 13:00 | Session II - Latest Knowledge and Research in Genetics Moderators: Ben Park, Adrian Trifa |
| 11:00 - 11:20 | Exploring Exosomal miRNAs in the Management of Breast Cancer Patients Ovidiu Bălăcescu |
| 11:20 - 11:35 | Germline Testing in Early Breast Cancer Patients - Distribution of Patogenic/Lightly Patogenic Variants in High Penetrance Genes Adrian Trifa |
| 11:35 - 11:50 | Germline Testing in Early Breast Cancer Patients - Distribution of Patogenic/Lightly Patogenic Variants in Moderate Penetrance Genes Andreea Cătană |
| 11:50 - 12:20 | Circulating Tumor DNA in Breast Cancer Ben Park (USA) |
| 12:20 - 12:30 | Discussions |
| 12:30 - 13:00 | Vtalks - Verzenios & eBC efficacy Nicoleta Antone, Simona Volovăț |
| 13:00 - 14:00 | Lunch break |
| 14:00 - 16:30 | Session III - Sharing Knowledge and Experience in Medical Oncology Moderators: Ben Park, Nicoleta Antone |
| 14:00 - 14:20 | Systemic Therapy in Breast Cancer Julie Gralow (USA) |
| 14:20- 14:40 | Systemic Therapy for Metastatic Breast Cancer Alexandru Eniu (Switzerland) |
| 14:40- 14:55 | Barriers for Breast Cancer Diagnosis and Treatment, Results- FLORA STUDY, in Collaboration with IARC, WHO Nicoleta Antone |
| 14:55- 15:10 | Oligometastatic Disease in Breast Cancer Gabriela Morar Bolba |
| 15:10 - 15:25 | Leptomeningeal Disease- Breast Cancer Center Experience Emanuela Rohozneanu |
| 15:25 - 15:40 | Why Do We Need Clinical Trials in Breast Cancer? Andrada Deac |
| 15:40 - 15:50 | Discussions |
| 15:50 - 16:10 | DESTINY-Breast03: Transforming the course of HER2+ mBC Andrei Ungureanu |
| 16:10 - 16:30 | The evolving HER2 spectrum: a new era in the treatment of HER2 Low expressing mBC Nicoleta Antone |
| 16:30 - 17:00 | Coffee Break |
| 17:00 - 18:00 | Session IV - Mentoring and International Programs for Young Oncologists Moderators: Ben Park, Julie Gralow, Alexandru Eniu |
| 17:00 - 18:00 | Round Table discussion : How Do We Choose Our Mentor? Ben Park (USA), Julie Gralow (USA), Aysegul Sahin (USA), Alexandru Eniu (Switzerland), Silvia Ilie (France), Nicoleta Antone |
| 18:00 | Closing Remarks Day 1 |
| 20:00 | Opening Cocktail |
| Day 2 Saturday, 21st of September 2024 |
|
| Time | Session |
| 08:30 - 10:30 | Session V - Sharing Knowledge and Research in Pathology and Surgery Moderators: Aysegul Sahin, Bogdan Fetica |
| 08:30- 08:45 | Minimally Invasive Surgical Approach at the Axillary Level in Early-Stage Breast Cancer Vlad Gâta |
| 08:45 - 09:00 | pCR in HER2 Positive Breast Cancer, A Single Centre Experience Bogdan Fetica |
| 09:00 - 09:20 | Predictive and Prognostic Biomarkers in Breast Cancer Aysegul Sahin (USA) |
| 09:20 - 09:30 | Discussions |
| 09:30 - 09:45 | Incidence and resolution of eribulin-induced peripheral neuropathy in locally advanced or metastatic breast cancer Simona Volovăț |
| 09:45 - 10:00 | The Response to the Challenges of 3L Treatment for MBC HER2+ Răzvan Curcă |
| 10:00 - 10:30 | Innovation and Progress in the M+B28anagement of Early and Metastatic TNBC Studies KN 355 and KN522 Răzvan Curcă |
| 10:30 - 11:00 | Coffee Break |
| 11:00 - 13:00 | Session VI - The Role of Surgery, Plastic Surgery and Radiotherapy in Breast Cancer Moderators: Dan Eniu, Daniela Martin |
| 11:00 - 11:20 | Autologous Tissue Total Breast Reconstruction for Breast Cancer- Tips and Tricks Dan Eniu |
| 11:20 - 11:40 | Prophylactic Mastectomy for Genetic Disorders. From Oncoplastic to Oncoesthetic Surgery Maximilian Muntean |
| 11:40 - 12:00 | Breast Cancer Radiation Therapy for Patients with Genetic Disorders Daniela Martin |
| 12:00 - 12:15 | Radiotherapy and Breast Reconstruction Surgery Marius Maxin |
| 12:15 - 12:30 | Difficult Clinical Scenarios in Everyday Practice Răzvan Curcă |
| 12:30 - 12:40 | Discussions |
| 12:40 - 13:00 | Give Her More Time and Simplicity with Treatment Administration and Monitoring, with Ibrance Alexandru Eniu |
| 13:00 - 14:00 | Lunch break |
| 14:00 - 17:20 | Session VII - Sharing Experiences and Ideas Across Romania Moderators: Julie Gralow, Alexandru Eniu, Julia Ferencz |
| 14:00 - 14:20 | Experience with Immunotherapy in Early and Advanced Breast Cancer Dragoș Median |
| 14:20 - 14:40 | Experience with CDK4/6 Inhibitors in Adjuvant Setting Simona Volovăț |
| 14:40 - 15:00 | Real World Data with CDK4/6 Inhibitors in Metastatic Setting Cristina Oprean |
| 15:00 - 15:20 | Quality in Oncology Treatment: The Role of Certification Karl Zähres (Germany) |
| 15:20 - 15:50 | Coffee Break |
| 15:50 - 16:05 | Psychological Adaptation to Illness in Patients Diagnosed with Breast Cancer Nicoleta Monica Jiboc |
| 16:05 - 16:20 | Patients Perspectives on Quality of Life and Clinical Trials Francisco Lozano(Spain) |
| 16:20 - 16:30 | Discussions |
| 16:30 - 16:50 | New Treatment Option for Patients with PIK3CA-Mutated, HR+, HER2– LA/mBC Cristina Oprean Anatomic-pathological protocol for handling, processing and reporting of breast biopsy and resection pieces Bogdan Fetica |
| 16:50 - 17:20 | Round Table: How can we PIK3 the right treatment for every patient with HR+ breast cancer? Cristina Oprean |
| 17:30 | Closing Remarks |
DESIGN YOUR TRAVEL SRL | str. Victor Babeş, nr. 3, biroul B, Cluj-Napoca, România | RO33853977, J12/3366/2014